GEN Exclusives

More »

GEN News Highlights

More »
Nov 24, 2009

Roche Earmarks €4M for Rare Disease Collaboration with Andalucian Region's DoH

  • Roche will invest €4 million ($5.98 million) into a new Medical Genome Project in collaboration with the Junta de Andalucia Department of Health. The three-year partnership, scheduled to start next year, aims to identify the genetic causes of rare diseases and develop new therapeutics that target gene-specific disorders. The overall goal will be the development of personalized therapies tailored to individuals’ genetic makeup. The project is the brainchild of the Spanish DoH, but Roche will retain the right of first refusal to license relevant discoveries. 

    Hands-on research for the project will be carried out in Seville and led by researchers at the Andalusian Genetic Plan and the Andalusian Program for Genetic Research and Genomics at Cartuja 93.

     



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?